Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Creating and Using Plastic Antibodies

2/7/2011

Kenneth J. Shea, Ph.D., Professor, Chemistry, School of Physical Sciences, University of California, Irvine

University of California, Irvine (UCI) researchers report that they have developed the world’s first “plastic antibodies” that have already been employed in live organisms to stop the spread of bee venom through the bloodstream of mice. The polymer nanoparticles were prepared by molecular imprinting, a technique similar to plaster casting. Unlike natural antibodies produced by live organisms and harvested for medical use, synthetic antibodies can be created in laboratories at a lower cost and have a longer shelf life, according to the scientists.


During this week’s podcast UCI team leader, Dr. Ken Shea, describes in detail both the plastic antibodies and the actual process used to manufacture them. He elaborates on the advantages of the novel antibodies vis-a-vis natural antibodies and explains the significance of the animal experiments that have already been carried out. Dr. Shea goes on to talk about current work being done in his lab and explores additional applications for plastic antibodies.

Kenneth J. Shea received his Ph.D. in Chemistry from The Pennsylvania State University and did his postdoc at California Institute of Technology. He is currently professor at and chair of the chemistry department of UCI. His research focuses on synthetic and mechanistic organic chemistry, polymer, and materials chemistry. Dr. Shea has been awarded seven U.S. patents and has been a consultant to over 10 companies.


Related content

Webinars

New Products

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll